Sirturo

Chemical Namebedaquiline
Dosage FormTablet (oral; 20mg, 100mg)
Drug ClassAntibacterials
SystemRespiratory
CompanyJanssen Pharmaceuticals, Inc.
Approval Year2012

Indication

  • Indicated as part of combination therapy for with pulmonary multi-drug resistant tuberculosis (MDR-TB) in adult and pediatric patients (5 years and older and weighing at least 15 kg)
Last updated on 5/11/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Sirturo (bedaquiline) Prescribing Information2012Janssen Therapeutics, Titusville, NJ